BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 15178639)

  • 41. Semicarbazide-Sensitive Amine Oxidase (SSAO) and Lysyl Oxidase (LOX) Association in Rat Aortic Vascular Smooth Muscle Cells.
    Manasieva V; Thakur S; Lione LA; Patel J; Baydoun A; Skamarauskas J
    Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358914
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The release of soluble VAP-1/SSAO by 3T3-L1 adipocytes is stimulated by isoproterenol and low concentrations of TNFalpha.
    García-Vicente S; Abella A; Viguerie N; Ros-Baró A; Camps M; Testar X; Palacín M; Zorzano A; Marti L
    J Physiol Biochem; 2005 Jun; 61(2):395-401. PubMed ID: 16180338
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short- and long-term insulin-like effects of monoamine oxidases and semicarbazide-sensitive amine oxidase substrates in cultured adipocytes.
    Carpéné C; Daviaud D; Boucher J; Bour S; Visentin V; Grès S; Duffaut C; Fontana E; Testar X; Saulnier-Blache JS; Valet P
    Metabolism; 2006 Oct; 55(10):1397-405. PubMed ID: 16979412
    [TBL] [Abstract][Full Text] [Related]  

  • 44. SSAO inhibitors suppress hepatocellular tumor growth in mice.
    Li R; Li H; Luo HJ; Lin ZX; Jiang ZW; Luo WH
    Cell Immunol; 2013; 283(1-2):61-9. PubMed ID: 23850964
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Blood-brain barrier dysfunction underlying Alzheimer's disease is induced by an SSAO/VAP-1-dependent cerebrovascular activation with enhanced Aβ deposition.
    Solé M; Esteban-Lopez M; Taltavull B; Fábregas C; Fadó R; Casals N; Rodríguez-Álvarez J; Miñano-Molina AJ; Unzeta M
    Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2189-2202. PubMed ID: 31047972
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Selective inhibitors of membrane-bound semicarbazide-sensitive amine oxidase (SSAO) activity in mammalian tissues.
    Kinemuchi H; Sugimoto H; Obata T; Satoh N; Ueda S
    Neurotoxicology; 2004 Jan; 25(1-2):325-35. PubMed ID: 14697907
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Inhibition of Semicarbazide-sensitive Amine Oxidase Reduces Atherosclerosis in Cholesterol-fed New Zealand White Rabbits.
    Wang SH; Yu TY; Hung CS; Yang CY; Lin MS; Su CY; Chen YL; Kao HL; Chuang LM; Tsai FC; Li HY
    Sci Rep; 2018 Jun; 8(1):9249. PubMed ID: 29915377
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Cloning and characterization of mouse vascular adhesion protein-1 reveals a novel molecule with enzymatic activity.
    Bono P; Salmi M; Smith DJ; Jalkanen S
    J Immunol; 1998 Jun; 160(11):5563-71. PubMed ID: 9605161
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Circulating soluble vascular adhesion protein 1 accounts for the increased serum monoamine oxidase activity in chronic liver disease.
    Kurkijärvi R; Yegutkin GG; Gunson BK; Jalkanen S; Salmi M; Adams DH
    Gastroenterology; 2000 Oct; 119(4):1096-103. PubMed ID: 11040196
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Different forms of human vascular adhesion protein-1 (VAP-1) in blood vessels in vivo and in cultured endothelial cells: implications for lymphocyte-endothelial cell adhesion models.
    Salmi M; Jalkanen S
    Eur J Immunol; 1995 Oct; 25(10):2803-12. PubMed ID: 7589075
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Effect of activity of semicarbazide-sensitive aminooxidases and cellular glutathione on the cytotoxic effect of allylamine, acrolein, and formaldehyde in human cultured endothelial cells].
    Pino R; Lyles GA
    Vopr Med Khim; 1997; 43(6):537-47. PubMed ID: 9503571
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Involvement of SSAO-mediated deamination in adipose glucose transport and weight gain in obese diabetic KKAy mice.
    Yu PH; Wang M; Fan H; Deng Y; Gubisne-Haberle D
    Am J Physiol Endocrinol Metab; 2004 Apr; 286(4):E634-41. PubMed ID: 14656718
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Semicarbazide-sensitive amine oxidase/vascular adhesion protein-1 deficiency reduces leukocyte infiltration into adipose tissue and favors fat deposition.
    Bour S; Caspar-Bauguil S; Iffiú-Soltész Z; Nibbelink M; Cousin B; Miiluniemi M; Salmi M; Stolen C; Jalkanen S; Casteilla L; Pénicaud L; Valet P; Carpéné C
    Am J Pathol; 2009 Mar; 174(3):1075-83. PubMed ID: 19218346
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Hydrogen peroxide derived from amine oxidation mediates the interaction between aminosugars and semicarbazide-sensitive amine oxidase.
    O'Sullivan J; Davey G; O'Sullivan M; Tipton KF
    J Neural Transm (Vienna); 2007; 114(6):751-6. PubMed ID: 17401531
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inactivation of Semicarbazide-Sensitive Amine Oxidase Stabilizes the Established Atherosclerotic Lesions via Inducing the Phenotypic Switch of Smooth Muscle Cells.
    Peng Y; Wang J; Zhang M; Niu P; Yang M; Yang Y; Zhao Y
    PLoS One; 2016; 11(4):e0152758. PubMed ID: 27043821
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Interaction of L-lysine and soluble elastin with the semicarbazide-sensitive amine oxidase in the context of its vascular-adhesion and tissue maturation functions.
    Olivieri A; O'Sullivan J; Fortuny LR; Vives IL; Tipton KF
    Biochim Biophys Acta; 2010 Apr; 1804(4):941-7. PubMed ID: 20079884
    [TBL] [Abstract][Full Text] [Related]  

  • 57. SSAO/VAP-1 in Cerebrovascular Disorders: A Potential Therapeutic Target for Stroke and Alzheimer's Disease.
    Unzeta M; Hernàndez-Guillamon M; Sun P; Solé M
    Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33805974
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Function-blocking antibodies to human vascular adhesion protein-1: a potential anti-inflammatory therapy.
    Kirton CM; Laukkanen ML; Nieminen A; Merinen M; Stolen CM; Armour K; Smith DJ; Salmi M; Jalkanen S; Clark MR
    Eur J Immunol; 2005 Nov; 35(11):3119-30. PubMed ID: 16224816
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Plasma VAP-1/SSAO activity predicts intracranial hemorrhages and adverse neurological outcome after tissue plasminogen activator treatment in stroke.
    Hernandez-Guillamon M; Garcia-Bonilla L; Solé M; Sosti V; Parés M; Campos M; Ortega-Aznar A; Domínguez C; Rubiera M; Ribó M; Quintana M; Molina CA; Alvarez-Sabín J; Rosell A; Unzeta M; Montaner J
    Stroke; 2010 Jul; 41(7):1528-35. PubMed ID: 20538694
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Semicarbazide-sensitive amine oxidase activation promotes adipose conversion of 3T3-L1 cells.
    Mercier N; Moldes M; El Hadri K; Fève B
    Biochem J; 2001 Sep; 358(Pt 2):335-42. PubMed ID: 11513731
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.